Drug intelligence / Profile preview

ciclopirox

Development stage
Approved
Lead developer
Sanofi
Modality
Small Molecules
Administration
Topical
01

Overview

Ciclopirox is a broad-spectrum topical antifungal agent used to treat mild to moderate fungal infections of the skin and nails. It is indicated for conditions such as onychomycosis (fungal nail infection), tinea pedis (athlete’s foot), tinea corporis (ringworm of the body), tinea cruris (jock itch), seborrheic dermatitis of the scalp, and cutaneous candidiasis. Ciclopirox acts primarily by chelating polyvalent cations like Fe3+ and Al3+, which inhibits metal-dependent enzymes responsible for peroxide degradation within fungal cells. This disrupts essential cellular processes including mitochondrial electron transport and energy production. Unlike azole antifungals that inhibit sterol synthesis in fungal membranes, ciclopirox’s unique mechanism also imparts antibacterial and anti-inflammatory properties by inhibiting prostaglandin and leukotriene synthesis through cyclooxygenase and 5-lipoxygenase inhibition[4][6][8]. It is available in various topical formulations including creams, gels, lotions, shampoos for scalp use, and nail lacquers[3][5].

Brand names
CiclodanLoproxCNL8 NailCNL-8 NailCNL 8 NailPedipirox-4Pedipirox4Pedipirox 4Penlac Nail LacquerLoprox TSCiclodan Kit
Other names
ciclopirox
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)COX

Beyond the preview

Go deeper on ciclopirox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciclopirox.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call